Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting
Oslo, Norway, 15 March 2023 - Targovax ASA (OSE: TRVX) today announces that an abstract describing its circular RNA platform has been accepted for poster presentation at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando, USA. The abstract describes the advantage of protein expression utilizing Targovax´proprietary circAde vector system. By comparing protein expression from circRNA and mRNA-based vectors, it is shown that the circAde-system out-performs conventional mRNA-based designs, both in terms of protein expression level and durability. Persistent